» Articles » PMID: 33430493

Mitochondrial DNA Replacement Techniques to Prevent Human Mitochondrial Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 12
PMID 33430493
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial DNA (mtDNA) diseases are a group of maternally inherited genetic disorders caused by a lack of energy production. Currently, mtDNA diseases have a poor prognosis and no known cure. The chance to have unaffected offspring with a genetic link is important for the affected families, and mitochondrial replacement techniques (MRTs) allow them to do so. MRTs consist of transferring the nuclear DNA from an oocyte with pathogenic mtDNA to an enucleated donor oocyte without pathogenic mtDNA. This paper aims to determine the efficacy, associated risks, and main ethical and legal issues related to MRTs. A bibliographic review was performed on the MEDLINE and Web of Science databases, along with searches for related clinical trials and news. A total of 48 publications were included for review. Five MRT procedures were identified and their efficacy was compared. Three main risks associated with MRTs were discussed, and the ethical views and legal position of MRTs were reviewed. MRTs are an effective approach to minimizing the risk of transmitting mtDNA diseases, but they do not remove it entirely. Global legal regulation of MRTs is required.

Citing Articles

Exogenous expression of ATP8, a mitochondrial encoded protein, from the nucleus .

Begelman D, Dixit B, Truong C, King C, Watson M, Schilling B Mol Ther Methods Clin Dev. 2024; 32(4):101372.

PMID: 39659757 PMC: 11629202. DOI: 10.1016/j.omtm.2024.101372.


Emerging Multi-omic Approaches to the Molecular Diagnosis of Mitochondrial Disease and Available Strategies for Treatment and Prevention.

Khaghani F, Hemmati M, Ebrahimi M, Salmaninejad A Curr Genomics. 2024; 25(5):358-379.

PMID: 39323625 PMC: 11420563. DOI: 10.2174/0113892029308327240612110334.


Mito-TEMPO Improves the Meiosis Resumption and Mitochondrial Function of Vitrified Sheep Oocytes via the Recovery of Respiratory Chain Activity.

Zhao X, Dilixiati A, Zhang L, Aihemaiti A, Song Y, Zhao G Animals (Basel). 2024; 14(1).

PMID: 38200883 PMC: 10778259. DOI: 10.3390/ani14010152.


Mitochondrial Transfer as a Novel Therapeutic Approach in Disease Diagnosis and Treatment.

Clemente-Suarez V, Martin-Rodriguez A, Yanez-Sepulveda R, Tornero-Aguilera J Int J Mol Sci. 2023; 24(10).

PMID: 37240194 PMC: 10218908. DOI: 10.3390/ijms24108848.


Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases.

Liu Y, Huang Y, Xu C, An P, Luo Y, Jiao L Int J Mol Sci. 2022; 23(24).

PMID: 36555691 PMC: 9788331. DOI: 10.3390/ijms232416053.


References
1.
Wang T, Sha H, Ji D, Zhang H, Chen D, Cao Y . Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell. 2014; 157(7):1591-604. DOI: 10.1016/j.cell.2014.04.042. View

2.
Wu K, Zhong C, Chen T, Zhang X, Tao W, Zhang J . Polar bodies are efficient donors for reconstruction of human embryos for potential mitochondrial replacement therapy. Cell Res. 2017; 27(8):1069-1072. PMC: 5539348. DOI: 10.1038/cr.2017.67. View

3.
Ma H, ONeil R, Marti Gutierrez N, Hariharan M, Zhang Z, He Y . Functional Human Oocytes Generated by Transfer of Polar Body Genomes. Cell Stem Cell. 2016; 20(1):112-119. PMC: 5218919. DOI: 10.1016/j.stem.2016.10.001. View

4.
Adashi E, Cohen I . Preventing Mitochondrial Diseases: Embryo-Sparing Donor-Independent Options. Trends Mol Med. 2018; 24(5):449-457. DOI: 10.1016/j.molmed.2018.03.002. View

5.
Greenfield A, Braude P, Flinter F, Lovell-Badge R, Ogilvie C, Perry A . Assisted reproductive technologies to prevent human mitochondrial disease transmission. Nat Biotechnol. 2017; 35(11):1059-1068. DOI: 10.1038/nbt.3997. View